Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT02291874 · COMPLETED
Trial details
- NCT number
- NCT02291874
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-08
- Primary completion
- 2016-07-07
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.